BC Week In Review | Oct 9, 2006
Company News

Oridis Biomed management update

Oridis Biomed GmbH , Graz, Austria   Business: Cancer, Metabolic, Microarrays   Hired: Wolfgang Senne as CFO; formerly CFO and CEO of Eurofins Scientific S.A.'s GeneScan Europe AG subsidiary; he replaces acting CFO and COO Reinhold...
BC Extra | Apr 16, 2005
Politics & Policy

EU requires certification of feed imports

The EU member states adopted a measure requiring that importers of corn gluten feed and brewers grain from the U.S. ensure that the feed is certified as being free of Bt10, an unauthorized GM corn....
BC Week In Review | Feb 24, 2003
Company News

Eurofins, GeneScan deal

Bioanalytical services company EUFI made a E7.5 million ($8 million) takeover bid for supply company GEP. EUFI will pay E1.10 for each GEP share, a 48% premium to GEP's Feb. 14 close at E 0.74....
BioCentury | Feb 24, 2003
Finance

Ebb & Flow

Investors typically pay a premium for biotech earnings, largely on the promise of future growth. Thus the fact that NPS Pharmaceuticals (NPSP) is getting Enzon on the cheap on a price-to-earnings basis implies that NPSP...
BC Extra | Feb 18, 2003
Company News

Eurofins to acquire GeneScan

Bioanalytical services company Eurofins Scientific (NM:EUFI) made a EUR 7.5 million ($8 million) takeover bid for supply company GeneScan Europe (NMarkt:GEP). EUFI will pay EUR 1.10 for each GEP share, a 48% premium to GEP's...
BioCentury | Feb 3, 2003
Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Notes 9/30 cash Years cash pre-cut 9 month operating loss 1/3/03 AeroGen (AEGN) 30% to 61 Also halted development of Aerodose insulin after it was unable to partner the...
BC Week In Review | Jan 13, 2003
Company News

GeneScan board of directors update

GeneScan Europe AG (NMarkt:GEP), Freiburg, Germany   Business: Agbio/Veterinary/Environmental   Resigned: Ulrich Birsner  ...
BC Week In Review | Jan 13, 2003
Company News

GeneScan agbio/veterinary/environmental news

GEP will restructure to focus on its AgroFood business. GEP subsidiary BioChip Technologies GmbH will lay off about 80 employees, bringing its headcount to 135, and will focus on biochip-based services. GEP expects restructuring costs...
BC Week In Review | Nov 11, 2002
Company News

GeneScan, LGC Ltd deal

GEP received a non-exclusive worldwide license from LGC to use CYP2D6*4 gene variant in GEP’s Pharm-O-Kin biochip pharmacogenetic typing assay. GEP said the CYP2D6*4 gene codes for an enzyme in the liver which is involved...
BioCentury | Nov 11, 2002
Finance

Ebb & Flow

Cephalon (CEPH) and Shire (LSE:SHP; SHPGY) put an exclamation point to the end of biotech's third quarter earnings season. Both provided upside surprises, bringing to 14 the number of profitable biotechs that beat their Street...
Items per page:
1 - 10 of 37
BC Week In Review | Oct 9, 2006
Company News

Oridis Biomed management update

Oridis Biomed GmbH , Graz, Austria   Business: Cancer, Metabolic, Microarrays   Hired: Wolfgang Senne as CFO; formerly CFO and CEO of Eurofins Scientific S.A.'s GeneScan Europe AG subsidiary; he replaces acting CFO and COO Reinhold...
BC Extra | Apr 16, 2005
Politics & Policy

EU requires certification of feed imports

The EU member states adopted a measure requiring that importers of corn gluten feed and brewers grain from the U.S. ensure that the feed is certified as being free of Bt10, an unauthorized GM corn....
BC Week In Review | Feb 24, 2003
Company News

Eurofins, GeneScan deal

Bioanalytical services company EUFI made a E7.5 million ($8 million) takeover bid for supply company GEP. EUFI will pay E1.10 for each GEP share, a 48% premium to GEP's Feb. 14 close at E 0.74....
BioCentury | Feb 24, 2003
Finance

Ebb & Flow

Investors typically pay a premium for biotech earnings, largely on the promise of future growth. Thus the fact that NPS Pharmaceuticals (NPSP) is getting Enzon on the cheap on a price-to-earnings basis implies that NPSP...
BC Extra | Feb 18, 2003
Company News

Eurofins to acquire GeneScan

Bioanalytical services company Eurofins Scientific (NM:EUFI) made a EUR 7.5 million ($8 million) takeover bid for supply company GeneScan Europe (NMarkt:GEP). EUFI will pay EUR 1.10 for each GEP share, a 48% premium to GEP's...
BioCentury | Feb 3, 2003
Finance

Restructuring watch

Restructuring watch Date Company Staff cuts Notes 9/30 cash Years cash pre-cut 9 month operating loss 1/3/03 AeroGen (AEGN) 30% to 61 Also halted development of Aerodose insulin after it was unable to partner the...
BC Week In Review | Jan 13, 2003
Company News

GeneScan board of directors update

GeneScan Europe AG (NMarkt:GEP), Freiburg, Germany   Business: Agbio/Veterinary/Environmental   Resigned: Ulrich Birsner  ...
BC Week In Review | Jan 13, 2003
Company News

GeneScan agbio/veterinary/environmental news

GEP will restructure to focus on its AgroFood business. GEP subsidiary BioChip Technologies GmbH will lay off about 80 employees, bringing its headcount to 135, and will focus on biochip-based services. GEP expects restructuring costs...
BC Week In Review | Nov 11, 2002
Company News

GeneScan, LGC Ltd deal

GEP received a non-exclusive worldwide license from LGC to use CYP2D6*4 gene variant in GEP’s Pharm-O-Kin biochip pharmacogenetic typing assay. GEP said the CYP2D6*4 gene codes for an enzyme in the liver which is involved...
BioCentury | Nov 11, 2002
Finance

Ebb & Flow

Cephalon (CEPH) and Shire (LSE:SHP; SHPGY) put an exclamation point to the end of biotech's third quarter earnings season. Both provided upside surprises, bringing to 14 the number of profitable biotechs that beat their Street...
Items per page:
1 - 10 of 37